Financing channel feed – Endpoints News

Financing channel feed

It’s a new $DAWN for Day One as startup pivots to an IPO for more funding to back its work in pediatric cancer

5 years ago

Startup sets out to tackle the gene therapy manufacturing crisis

5 years ago

Vik Bajaj's startup incubator at Foresite uncloaks an immunology player with a lead TYK2 inhibitor in tow

5 years ago

Focused on the cell therapy manufacturing bottleneck, Cellares turbocharges plans for 'shuttle' tech

5 years ago

A UK-based startup looks to beat Spark's Luxturna at its own game with programmable cell platform for eye disease

5 years ago

Can a topical treatment beat blockbuster eye injectables? A Swiss biotech has the cash now to find out

5 years ago

Personalized electric stimulation for epilepsy, depression? Morningside bets $17.5M on an idea dating back to Roman Empire

5 years ago

Vivek Ramaswamy and Matt Gline swoop into Nasdaq on the wings of Jim Momtazee's SPAC with a $7B-plus Roivant debut ready to do some deals

5 years ago

Looking to reinvent those troubled AAVs you've been reading about, investors back a $110M reboot effort

5 years ago

The company behind AstraZeneca's Covid-19 vaccine just went public, weeks after completing monster Series B, as Werewolf also makes the Nasdaq leap

5 years ago

Forge Biologics bags $120M round as it looks to scale AAV manufacturing for Krabbe disease treatment

5 years ago

The biotech craze hits the Nordics, driving a record-high $62M Series A for a Copenhagen-based ADC player

5 years ago

US ups funding for Moderna Covid-19 vaccine as total nears $6B

5 years ago

Boundless Bio raises $105M in effort to reimagine targeted cancer therapy

5 years ago

Fueled with a fresh half-billion dollars as AI investments boom, Exscientia is hitting the gas on drug development

5 years ago

Arch Oncology thinks it can stand out in the red-hot CD47 field, and it's taking $105M in new cash to prove it

5 years ago

Christoph Westphal and the crew at Novartis-backed TScan aren't waiting to take their preclinical TCR pitch to Nasdaq

5 years ago

April showers bring more biotechs to Nasdaq, as Rain and Impel bump 2021's total raise above $6B

5 years ago

Radiopharma remains hot as Germany's ITM raises $109M to advance neuroendocrine cancer program

5 years ago

Early Zymergen investor Jenny Rooke reflects on 'chimeras' in biotech, what it takes to spot a $500M gem

5 years ago

Zymergen's bid to disrupt a $3T industrial manufacturing market goes viral, earning a massive $500M IPO

5 years ago

On the heels of $250M launch, Centessa barges ahead with an IPO to fuel its 10-in-1 Medicxi pipeline

5 years ago

An EU biotech looks to rewrite the ugly history of phosphatases, and it's taking $24M in funding to get off the ground

5 years ago

On the hunt for bugs outside the gut, Seed Health snares $40M round to advance pipeline with the help of George Church

5 years ago

First page Previous page 76 77 787980 81 82 Next page Last page